We’re excited to announce a $100 million Series C financing to advance our pipeline of selective ion channel modulators as non-opioid treatments for pain and sensory hyperexcitability disorders. Our lead program targets NaV1.8, a promising approach for meaningful analgesia with a reduced risk of abuse. We are also excited to explore the potential of sodium channels and other genetically and clinically validated targets to treat pain and sensory hyperexcitability disorders. Thank you to our investors: Novo Holdings for leading the round, and OrbiMed, Wellington Management, Mission BioCapital, BSQUARED Capital Inc., and our existing investors for participating. Read the press release here: https://lnkd.in/gSFhUNc9 We also launched a new website! Learn more about how we're "owning the action potential" to deliver innovative therapies: https://lnkd.in/gWFt3pQk #nonopioidtherapies #painmanagement #pain #drugdiscovery #ionchannels #biotech #bayarea #financing #venturecapital
SiteOne Therapeutics, Inc.
Biotechnology Research
South San Francisco, CA 1,697 followers
Owning the Action Potential
About us
SiteOne Therapeutics is a biopharmaceutical company advancing a novel class of highly selective small molecule inhibitors targeting NaV1.7, NaV1.8, and other voltage-gated ion channels to treat sensory hyperexcitability disorders such as chronic cough, itch, and pain. Since its inception, SiteOne has been dedicated to the development of safe and effective pain therapeutics without the significant addiction potential and side effects of opioids. The company is also advancing additional novel drug candidates that exhibit precise selectivity for individual ion channel subtypes to treat other sensory hyperexcitability disorders such as chronic cough and chronic ocular surface pain.
- Website
-
https://siteonetherapeutics.com/
External link for SiteOne Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- South San Francisco, CA
- Type
- Privately Held
Locations
-
Primary
Get directions
South San Francisco, CA 94080, US